New malaria treatment plan put to the test in peru
NCT ID NCT05361486
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at whether a new way to treat Malaria Vivax is practical for healthcare workers in Peru. The plan includes a simple test to check a patient's G6PD enzyme level before giving one of two medicines, tafenoquine or primaquine. Researchers trained healthcare providers and followed up with patients after 3 days to see if the new steps were followed correctly. 187 patients took part, and the goal was to see if this approach could work in real-world clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA VIVAX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nauta Nucleo- Base
Nauta, Loreto, 16310, Peru
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can At-Home malaria pills work as well as supervised care?
- New malaria combo aims to stop relapses for good
- Early malaria vaccine trial halted โ what we know
- Malaria-Fighting drug given to entire villages shows promise
- Malaria elimination experiment: entire peruvian villages to receive mass drug dosing
- New malaria vaccine vivaxin enters first human tests